A unique protein designed by Cedars-Sinai Cancer investigators can cross the protective blood–brain barrier safely and deliver therapy directly into cancerous tumor cells, a preclinical study shows.

A new research paper was published in , Volume 16, on February 18, 2025, titled "Robust p53 phenotypes and prospective downstream targets in telomerase-immortalized human cells." ...

A 25-year-old woman from the Poyntzpass area has said life has become a "complete whirlwind" after a trip to Turkey for a ...

Allogene Therapeutics published new long-term follow-up data on cemacabtagene ansegedleucel, showing the investigative ...

Dr Grace Adjoa Ocansey, a Clinical Epidemiologist, has suggested that the National Health Insurance Scheme (NHIS) should be ...

Former Independent Electoral and Boundaries Commission (IEBC) chairperson Wafula Chebukati battled brain cancer until he died ...

Former Independent Electoral and Boundaries Commission (IEBC) chairperson Wafula Chebukati had a cancerous brain tumor that was recurrent.

According to studies, eating the fruit once every day is enough to protect your DNA by 60% - reducing your risk of chronic ...

GHA specialists are actively looking into lowering the age of bowel cancer screening, but before doing so, the team are ...

A bump on the eyelid can be painful or painless depending on its type and cause An expert explains the most common reasons ...

A Sunshine Coast mum has called for more comprehensive eye tests for kids after her four-year-old’s eye was removed following ...